iShares Nasdaq US Biotechnology
(BTEK)
£5.04
Previous business day’s close price
+£0.05 (+1.05%)
max available period
£3.91
£5.65
04 Jan 21
09 May 24
Details
This ETF tracks Nasdaq listed companies primarily engaged in biomedical research to develop new treatments and cures for human disease, via the Nasdaq Biotechnology index. This ETF reinvests income.
Ticker: BTEK
ISIN: IE00BYXG2H39
Ticker: BTEK
ISIN: IE00BYXG2H39
Key information
ETF Breakdown
AMGEN Inc.
8.6%
Vertex Pharmaceuticals, Inc.
8.0%
Regeneron Pharmaceuticals, Inc.
7.9%
Gilead Sciences, Inc.
7.8%
Astrazeneca plc
4.8%
Moderna Inc
4.6%
Biogen Inc
3.4%
Illumina Inc
2.2%
Alnylam Pharmaceuticals Inc
2.0%
Biomarin Pharmaceutical Inc.
1.7%
Viatris Inc
1.5%
Neurocrine Biosciences, Inc.
1.5%
Sanofi
1.5%
Royalty Pharma plc
1.4%
Medpace Holdings Inc
1.3%
Sarepta Therapeutics Inc
1.3%
Incyte Corp.
1.3%
argenx SE
1.3%
United Therapeutics Corp
1.2%
Myovant Sciences Ltd
1.0%
BioNTech SE
0.9%
Ascendis Pharma A/S
0.9%
Exelixis Inc
0.8%
Intra‑Cellular Therapies Inc
0.8%
Jazz Pharmaceuticals plc
0.8%
Vaxcyte Inc
0.7%
BeiGene Ltd
0.7%
Cytokinetics Inc
0.7%
Ionis Pharmaceuticals Inc
0.7%
Revolution Medicines Inc
0.7%
ImmunityBio Inc
0.7%
Apellis Pharmaceuticals Inc
0.6%
Blueprint Medicines Corp
0.6%
Halozyme Therapeutics Inc.
0.5%
BridgeBio Pharma Inc
0.5%
Krystal Biotech Inc
0.5%
CRISPR Therapeutics AG
0.5%
Alpine Immune Sciences Inc
0.5%
Alkermes plc
0.5%
Canticle Pharmaceuticals Inc
0.4%
Immunovant Inc
0.4%
Nuvalent Inc
0.4%
Insmed Inc
0.4%
Ultragenyx Pharmaceutical Inc.
0.4%
Legend Biotech Corp
0.4%
Axsome Therapeutics Inc
0.4%
Fortrea Holdings Inc
0.4%
Lion Biotechnologies Inc
0.4%
SpringWorks Therapeutics Inc
0.4%
Xenon Pharmaceuticals Inc
0.3%
Amicus Therapeutics Inc
0.3%
Crinetics Pharmaceuticals Inc
0.3%
Ideaya Biosciences Inc
0.3%
Acadia Pharmaceuticals Inc
0.3%
Arrowhead Pharmaceuticals Inc.
0.3%
Summit Therapeutics Inc
0.3%
Arcellx Inc
0.3%
Merus N.V
0.3%
PTC Therapeutics Inc
0.3%
Rhythm Pharmaceuticals Inc.
0.3%
Vericel Corp
0.3%
Arvinas Operations Inc
0.2%
Denali Therapeutics Inc
0.2%
Geron Corp.
0.2%
Guardant Health Inc
0.2%
Vera Therapeutics Inc
0.2%
Intellia Therapeutics Inc
0.2%
Keros Therapeutics Inc
0.2%
Kymera Therapeutics Inc
0.2%
Amphastar Pharmaceuticals Inc
0.2%
Deciphera Pharmaceuticals Inc
0.2%
Dyne Therapeutics Inc
0.2%
Rocket Pharmaceuticals Inc
0.2%
Sana Biotechnology Inc
0.2%
Avidity Biosciences Inc
0.2%
Immunocore Holdings plc
0.2%
Structure Therapeutics Adr Inc
0.2%
Agios Pharmaceuticals Inc
0.2%
Apogee Therapeutics Ord Shs
0.2%
Beam Therapeutics Inc
0.2%
Recursion Pharmaceuticals Inc
0.2%
Syndax Pharmaceuticals Inc
0.2%
Twist Bioscience Corp
0.2%
Harmony Biosciences Holdings Inc
0.2%
Myriad Genetics, Inc.
0.2%
Avadel Pharmaceuticals Ord
0.2%
Inhibrx Inc
0.2%
Supernus Pharmaceuticals Inc
0.2%
Edgewise Therapeutics Inc
0.2%
Fusion Pharmaceuticals Inc
0.2%
Kura Oncology Inc
0.2%
Veracyte Inc
0.2%
Adma Biologics Inc
0.2%
Ardelyx Inc
0.2%
Day One Biopharmaceuticals Inc
0.2%
Dynavax Technologies Corp.
0.2%
Protagonist Therapeutics Inc
0.2%
Morphic Holding Inc
0.1%
NovoCure Ltd
0.1%
Ligand Pharmaceuticals, Inc.
0.1%
Xencor Inc
0.1%
4D Molecular Therapeutics Inc
0.1%
Collegium Pharmaceutical Inc
0.1%
Cullinan Oncology Inc
0.1%
Genmab
0.1%
Ironwood Pharmaceuticals Inc
0.1%
Mirum Pharmaceuticals Inc
0.1%
Pacira BioSciences Inc
0.1%
AbCellera Biologics Inc
0.1%
Akero Therapeutics Inc
0.1%
Mannkind Corp
0.1%
Prothena Corporation plc
0.1%
Tarsus Pharmaceuticals Inc
0.1%
Vir Biotechnology Inc
0.1%
Blk Ics Usd Liq Agency Dis
0.1%
Innoviva Inc
0.1%
Maravai LifeSciences Holdings Inc
0.1%
Scholar Rock Holding Corp
0.1%
Verona Pharma Plc
0.1%
Biocryst Pharmaceuticals Inc.
0.1%
EyePoint Pharmaceuticals Inc
0.1%
Macrogenics Inc
0.1%
Alx Oncology Holdings Inc
< 0.1%
Arcutis Biotherapeutics Inc
< 0.1%
Bicycle Therapeutics Plc
< 0.1%
Relay Therapeutics Inc
< 0.1%
Sage Therapeutics Inc
< 0.1%
Silverback Therapeutics Inc
< 0.1%
Tango Therapeutics Inc
< 0.1%
Zai Lab Limited
< 0.1%
Zentalis Pharmaceuticals Inc
< 0.1%
89bio Inc
< 0.1%
ANI Pharmaceuticals Inc
< 0.1%
Arcturus Therapeutics Holdings Inc
< 0.1%
Cogent Biosciences Inc
< 0.1%
Disc Medicine Inc Ord
< 0.1%
Enliven Therapeutics Inc Ord
< 0.1%
Grifols SA
< 0.1%
Kiniksa Pharmaceuticals Ltd
< 0.1%
Pliant Therapeutics Inc
< 0.1%
Regenxbio Inc
< 0.1%
Castle Biosciences Inc
< 0.1%
Evolus Inc
< 0.1%
HUTCHMED (China) Limited
< 0.1%
Novavax, Inc.
< 0.1%
Nurix Therapeutics Inc
< 0.1%
SIGA Technologies Inc
< 0.1%
Savara Inc
< 0.1%
Y‑Mabs Therapeutics Inc
< 0.1%
AnaptysBio Inc
< 0.1%
Autolus Therapeutics Adr Plc
< 0.1%
Centessa Pharmaceuticals plc
< 0.1%
CureVac N.V.
< 0.1%
Galapagos NV
< 0.1%
Lyell Immunopharma Inc
< 0.1%
ORIC Pharmaceuticals Inc
< 0.1%
Ocular Therapeutix Inc
< 0.1%
Olema Pharmaceuticals Inc
< 0.1%
Omniab Inc
< 0.1%
Phathom Pharmaceuticals Inc
< 0.1%
Prime Medicine Ord Shs
< 0.1%
Verve Therapeutics Inc
< 0.1%
Wave Life Sciences Ltd.
< 0.1%
Zymeworks Inc
< 0.1%
Adaptive Biotechnologies Corp
< 0.1%
Alector Inc
< 0.1%
Allogene Therapeutics Inc
< 0.1%
Arbutus Biopharma Corp
< 0.1%
Cabaletta Bio Inc
< 0.1%
Editas Medicine Inc
< 0.1%
Fulcrum Therapeutics Inc
< 0.1%
Humacyte Inc
< 0.1%
KalVista Pharmaceuticals Inc
< 0.1%
Mineralys Therapeutics Ord
< 0.1%
Pacific Biosciences of California Inc
< 0.1%
PetIQ Inc
< 0.1%
Replimune Group Inc
< 0.1%
Taysha Gene Therapies Inc
< 0.1%
Theravance Biopharma Inc
< 0.1%
Third Harmonic Bio Ord Shs
< 0.1%
UroGen Pharma Ltd
< 0.1%
ATAI Life Sciences N.V.
< 0.1%
Acelyrin Inc.
< 0.1%
Amarin Corp
< 0.1%
Biomea Fusion Inc
< 0.1%
Caribou Biosciences Inc
< 0.1%
Erasca Inc
< 0.1%
Harrow Health Inc
< 0.1%
ITeos Therapeutics Inc
< 0.1%
Lexicon Pharmaceuticals Inc
< 0.1%
MaxCyte Inc
< 0.1%
MeiraGTx Holdings plc
< 0.1%
Nautilus Biotechnology Inc
< 0.1%
Phibro Animal Health Corp.
< 0.1%
Precigen Inc
< 0.1%
Revance Therapeutics Inc
< 0.1%
Terns Pharmaceuticals Inc
< 0.1%
Tourmaline Bio Inc
< 0.1%
Travere Therapeutics Inc
< 0.1%
Voyager Therapeutics Inc
< 0.1%
Ac Immune Sa
< 0.1%
Anavex Life Sciences Corporation
< 0.1%
Atea Pharmaceuticals Inc
< 0.1%
Ovid Therapeutics Inc
< 0.1%
RAPT Therapeutics Inc
< 0.1%
Vanda Pharmaceuticals Inc
< 0.1%
Xeris Biopharma Holdings Inc
< 0.1%
23Andme Holding Class A
< 0.1%
Bluebird bio Inc
< 0.1%
Coherus Biosciences Inc
< 0.1%
Exscientia Plc
< 0.1%
Ventyx Biosciences Inc
< 0.1%
uniQure N.V.
< 0.1%
Aclaris Therapeutics Inc
< 0.1%
Amylyx Pharmaceuticals Inc
< 0.1%
Marinus Pharmaceuticals Inc
< 0.1%
Reneo Pharmaceuticals Inc
< 0.1%
Others
< 0.1%
No holdings found.
Please try a different search.
Please try a different search.
North America
81.1%
Europe ex‑UK
6.1%
UK
5.2%
Asia ex‑Japan
0.1%
Emerging Markets
< 0.1%
Rest of the World
6.9%
Healthcare
57.4%
Industrial
21.0%
Technology
8.0%
Consumer
< 0.1%
Sector ‐ Other
13.0%
Why InvestEngine
Unbeatable value
Build your own portfolio commission free or leave it to our experts for just 0.25%.
Zero‑ISA fees. SIPPs from 0.15%.
Full cost details (ETF costs apply)
Zero‑ISA fees. SIPPs from 0.15%.
Full cost details (ETF costs apply)
Choice of 620+ ETFs
Low cost, diversified, index‑tracking of stock markets, bonds and commodities.
View our ETF range
View our ETF range
Actionable insights
Know exactly which companies, sectors and regions are in your portfolio.
Powerful automation
Grow your wealth the easy way with automated investing features
Easy diversification
Fractional investing lets you put as little as £1 in any ETF.
DIY or Managed
Build and manage your own portfolio or leave it to us.
